TechnipFMC CapEx decreased by 41.2% to $55.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.0%, from $61.80M to $55.60M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 13.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.70M | $47.30M | $60.50M | $27.30M | $36.10M | $30.90M | $63.60M | $57.30M | $52.80M | $43.60M | $71.50M | $52.00M | $50.80M | $52.60M | $126.20M | $61.80M | $83.60M | $77.30M | $94.50M | $55.60M |
| QoQ Change | — | +19.1% | +27.9% | -54.9% | +32.2% | -14.4% | +105.8% | -9.9% | -7.9% | -17.4% | +64.0% | -27.3% | -2.3% | +3.5% | +139.9% | -51.0% | +35.3% | -7.5% | +22.3% | -41.2% |
| YoY Change | — | — | — | — | -9.1% | -34.7% | +5.1% | +109.9% | +46.3% | +41.1% | +12.4% | -9.2% | -3.8% | +20.6% | +76.5% | +18.8% | +64.6% | +47.0% | -25.1% | -10.0% |